This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Small RNA modifications: regulatory molecules and potential applications
Journal of Hematology & Oncology Open Access 22 June 2023
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bouchie, A. Companies in footrace to deliver RNAi. Nat Biotechnol 30, 1154–1155 (2012). https://doi.org/10.1038/nbt1212-1154
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1212-1154
This article is cited by
-
Small RNA modifications: regulatory molecules and potential applications
Journal of Hematology & Oncology (2023)
-
Alnylam's RNAi therapy targets amyloid disease
Nature Biotechnology (2015)
-
Minimal-length Synthetic shRNAs Formulated with Lipid Nanoparticles are Potent Inhibitors of Hepatitis C Virus IRES-linked Gene Expression in Mice
Molecular Therapy - Nucleic Acids (2013)